Rusfertide Treatment Beneficial for Patients With Polycythemia Vera

THURSDAY, Feb. 22, 2024 -- For patients with polycythemia vera, rusfertide treatment reduces the use of phlebotomy and maintains hematocrit of less than 45 percent, according to a study published in the Feb. 22 issue of the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news